Branden R Sosa1, YingZhen Niu1,2, Kathleen Turajane1, Kevin Staats3,4, Vincentius Suhardi1, Alberto Carli1, Vincent Fischetti5, Mathias Bostrom1, Xu Yang1. 1. Hospital for Special Surgery, New York, New York, USA. 2. Hebei Medical University Third Affiliated Hospital, Department of Joint Surgery, Hebei Medical University Third Affiliated Hospital, Shijiazhuang, China. 3. Hospital for Special Surgery, Department of Orthopedics and Trauma Surgery, New York, New York, USA. 4. Medical University of Vienna, Department of Orthopedics and Trauma Surgery, Vienna, Austria. 5. The Rockefeller University, New York, New York, USA.
Abstract
AIMS: Current treatments of prosthetic joint infection (PJI) are minimally effective against Staphylococcus aureus biofilm. A murine PJI model of debridement, antibiotics, and implant retention (DAIR) was used to test the hypothesis that PlySs2, a bacteriophage-derived lysin, can target S. aureus biofilm and address the unique challenges presented in this periprosthetic environment. METHODS: The ability of PlySs2 and vancomycin to kill biofilm and colony-forming units (CFUs) on orthopaedic implants were compared using in vitro models. An in vivo murine PJI model of DAIR was used to assess the efficacy of a combination of PlySs2 and vancomycin on periprosthetic bacterial load. RESULTS: PlySs2 treatment reduced 99% more CFUs and 75% more biofilm compared with vancomycin in vitro. A combination of PlySs2 and vancomycin in vivo reduced the number of CFUs on the surface of implants by 92% and in the periprosthetic tissue by 88%. CONCLUSION: PlySs2 lysin was able to reduce biofilm, target planktonic bacteria, and work synergistically with vancomycin in our in vitro models. A combination of PlySs2 and vancomycin also reduced bacterial load in periprosthetic tissue and on the surface of implants in a murine model of DAIR treatment for established PJI. Cite this article: Bone Joint J 2020;102-B(7 Supple B):3-10.
AIMS: Current treatments of prosthetic joint infection (PJI) are minimally effective against Staphylococcus aureus biofilm. A murine PJI model of debridement, antibiotics, and implant retention (DAIR) was used to test the hypothesis that PlySs2, a bacteriophage-derived lysin, can target S. aureus biofilm and address the unique challenges presented in this periprosthetic environment. METHODS: The ability of PlySs2 and vancomycin to kill biofilm and colony-forming units (CFUs) on orthopaedic implants were compared using in vitro models. An in vivo murine PJI model of DAIR was used to assess the efficacy of a combination of PlySs2 and vancomycin on periprosthetic bacterial load. RESULTS: PlySs2 treatment reduced 99% more CFUs and 75% more biofilm compared with vancomycin in vitro. A combination of PlySs2 and vancomycin in vivo reduced the number of CFUs on the surface of implants by 92% and in the periprosthetic tissue by 88%. CONCLUSION: PlySs2 lysin was able to reduce biofilm, target planktonic bacteria, and work synergistically with vancomycin in our in vitro models. A combination of PlySs2 and vancomycin also reduced bacterial load in periprosthetic tissue and on the surface of implants in a murine model of DAIR treatment for established PJI. Cite this article: Bone Joint J 2020;102-B(7 Supple B):3-10.
Authors: Upneet K Sokhi; Yunwei Xia; Branden Sosa; Kathleen Turajane; Sita N Nishtala; Tania Pannellini; Mathias P Bostrom; Alberto V Carli; Xu Yang; Lionel B Ivashkiv Journal: J Bone Miner Res Date: 2022-01-03 Impact factor: 6.741
Authors: Mustafa Akkaya; Georges Vles; Iman Godarzi Bakhtiari; Amir Sandiford; Jochen Salber; Thorsten Gehrke; Mustafa Citak Journal: Int Orthop Date: 2022-01-04 Impact factor: 3.075
Authors: Shota Higashihira; Stefanie Jan Simpson; Christopher David Collier; Roman Michael Natoli; Mizuho Kittaka; Edward Michael Greenfield Journal: Clin Orthop Relat Res Date: 2022-05-17 Impact factor: 4.755
Authors: Anabelle Visperas; Daniel Santana; Minseon Ju; Nathalie B Milbrandt; Yu Hsin Tsai; Sameera Wickramasinghe; Alison K Klika; Nicolas S Piuzzi; Anna Cristina S Samia; Carlos A Higuera-Rueda Journal: J Bone Jt Infect Date: 2022-04-20
Authors: Melissa Karau; Suzannah Schmidt-Malan; Jay Mandrekar; Dario Lehoux; Raymond Schuch; Cara Cassino; Robin Patel Journal: J Bone Jt Infect Date: 2022-07-27
Authors: Anabelle Visperas; Daniel Santana; Alison K Klika; Carlos A Higuera-Rueda; Nicolas S Piuzzi Journal: J Orthop Res Date: 2022-05-06 Impact factor: 3.102